Cargando…
γ-H2AX: A Novel Prognostic Marker in a Prognosis Prediction Model of Patients with Early Operable Non-Small Cell Lung Cancer
Cancer is a leading cause of death worldwide and the prognostic evaluation of cancer patients is of great importance in medical care. The use of artificial neural networks in prediction problems is well established in human medical literature. The aim of the current study was to assess the prognosti...
Autores principales: | Chatzimichail, E., Matthaios, D., Bouros, D., Karakitsos, P., Romanidis, K., Kakolyris, S., Papashinopoulos, G., Rigas, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910456/ https://www.ncbi.nlm.nih.gov/pubmed/24527431 http://dx.doi.org/10.1155/2014/160236 |
Ejemplares similares
-
γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer
por: Matthaios, Dimitrios, et al.
Publicado: (2012) -
BRCA1 and γH2AX as independent prognostic markers in oral squamous cell carcinoma
por: Oliveira-Costa, Joao Paulo, et al.
Publicado: (2014) -
Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma
por: Hountis, Panagiotis, et al.
Publicado: (2012) -
Genome Instability and γH2AX
por: Georgoulis, Anastasios, et al.
Publicado: (2017) -
Generation of an alpaca-derived nanobody recognizing γ-H2AX
por: Rajan, Malini, et al.
Publicado: (2015)